B lymphocytes contribute to autoimmune disease pathogenesis

Current trends and clinical implications

Joseph Tuscano, Geoffrey S. Harris, Thomas F. Tedder

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Abnormal B lymphocytes influence the pathogenesis of many autoimmune diseases, in addition to serving as the origin of pathogenic autoantibodies. Although aberrant B cell function and autoimmunity have complex polygenic origins, recent studies in mouse models of autoimmune diseases have revealed overlapping defects in signal transduction pathways that alter B cell survival or activation, and lead to an autoimmune phenotype. Discovery of these important signaling pathways in mice has lead to an intense search for B cell abnormalities that correlate with autoimmune diseases in humans. This search has identified potential targets for therapeutic intervention that are the focus of planned and ongoing human clinical trials. This promises an arsenal of highly targeted, less toxic therapies focused on restoring normal B cell function that will eliminate pathogenic autoantibodies and replace the current use of immunosuppressive drugs.

Original languageEnglish (US)
Pages (from-to)101-108
Number of pages8
JournalAutoimmunity Reviews
Volume2
Issue number2
DOIs
StatePublished - Mar 2003

Fingerprint

Autoimmune Diseases
B-Lymphocytes
Autoantibodies
Poisons
Immunosuppressive Agents
Autoimmunity
Signal Transduction
Cell Survival
Clinical Trials
Phenotype
Therapeutics
Pharmaceutical Preparations

Keywords

  • B lymphocyte
  • CD19
  • CD20
  • CD22
  • Immunotherapy
  • Signal transduction

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

B lymphocytes contribute to autoimmune disease pathogenesis : Current trends and clinical implications. / Tuscano, Joseph; Harris, Geoffrey S.; Tedder, Thomas F.

In: Autoimmunity Reviews, Vol. 2, No. 2, 03.2003, p. 101-108.

Research output: Contribution to journalArticle

@article{630383e461de483890f3cecdce58519e,
title = "B lymphocytes contribute to autoimmune disease pathogenesis: Current trends and clinical implications",
abstract = "Abnormal B lymphocytes influence the pathogenesis of many autoimmune diseases, in addition to serving as the origin of pathogenic autoantibodies. Although aberrant B cell function and autoimmunity have complex polygenic origins, recent studies in mouse models of autoimmune diseases have revealed overlapping defects in signal transduction pathways that alter B cell survival or activation, and lead to an autoimmune phenotype. Discovery of these important signaling pathways in mice has lead to an intense search for B cell abnormalities that correlate with autoimmune diseases in humans. This search has identified potential targets for therapeutic intervention that are the focus of planned and ongoing human clinical trials. This promises an arsenal of highly targeted, less toxic therapies focused on restoring normal B cell function that will eliminate pathogenic autoantibodies and replace the current use of immunosuppressive drugs.",
keywords = "B lymphocyte, CD19, CD20, CD22, Immunotherapy, Signal transduction",
author = "Joseph Tuscano and Harris, {Geoffrey S.} and Tedder, {Thomas F.}",
year = "2003",
month = "3",
doi = "10.1016/S1568-9972(02)00148-9",
language = "English (US)",
volume = "2",
pages = "101--108",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - B lymphocytes contribute to autoimmune disease pathogenesis

T2 - Current trends and clinical implications

AU - Tuscano, Joseph

AU - Harris, Geoffrey S.

AU - Tedder, Thomas F.

PY - 2003/3

Y1 - 2003/3

N2 - Abnormal B lymphocytes influence the pathogenesis of many autoimmune diseases, in addition to serving as the origin of pathogenic autoantibodies. Although aberrant B cell function and autoimmunity have complex polygenic origins, recent studies in mouse models of autoimmune diseases have revealed overlapping defects in signal transduction pathways that alter B cell survival or activation, and lead to an autoimmune phenotype. Discovery of these important signaling pathways in mice has lead to an intense search for B cell abnormalities that correlate with autoimmune diseases in humans. This search has identified potential targets for therapeutic intervention that are the focus of planned and ongoing human clinical trials. This promises an arsenal of highly targeted, less toxic therapies focused on restoring normal B cell function that will eliminate pathogenic autoantibodies and replace the current use of immunosuppressive drugs.

AB - Abnormal B lymphocytes influence the pathogenesis of many autoimmune diseases, in addition to serving as the origin of pathogenic autoantibodies. Although aberrant B cell function and autoimmunity have complex polygenic origins, recent studies in mouse models of autoimmune diseases have revealed overlapping defects in signal transduction pathways that alter B cell survival or activation, and lead to an autoimmune phenotype. Discovery of these important signaling pathways in mice has lead to an intense search for B cell abnormalities that correlate with autoimmune diseases in humans. This search has identified potential targets for therapeutic intervention that are the focus of planned and ongoing human clinical trials. This promises an arsenal of highly targeted, less toxic therapies focused on restoring normal B cell function that will eliminate pathogenic autoantibodies and replace the current use of immunosuppressive drugs.

KW - B lymphocyte

KW - CD19

KW - CD20

KW - CD22

KW - Immunotherapy

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=0141923537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141923537&partnerID=8YFLogxK

U2 - 10.1016/S1568-9972(02)00148-9

DO - 10.1016/S1568-9972(02)00148-9

M3 - Article

VL - 2

SP - 101

EP - 108

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 2

ER -